Bure Equity is a Swedish investment company that holds a diversified portfolio of listed and unlisted companies, focusing on long-term active ownership and value creation. The portfolio spans technology, medtech, industrial, and financial sectors, with significant exposure to high-tech and growth-oriented businesses. Key holdings include Cavotec, Mycronic, Ovzon, Vitrolife, Xvivo, Yubico, Allgon, Atle, BioLamina, Mentimeter, Mercuri International, My Driving Academy, Nodica, and Silex Microsystems. Bure acquired a stake in Silex, a MEMS foundry, in 2025. The company was founded in 1992 from the winding up of Sweden's wage earner investment funds and listed on Nasdaq Stockholm in 1993.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Asset Management Homepage bure.se/en/home-en
Sector Financial Services IR page bure.se/en/investors
Tags
holding company, active ownership, technology, medtech, industrial, financial services, diversified portfolio, long-term investment, Cavotec, Mycronic, Ovzon, Vitrolife, Xvivo, Yubico, Allgon, Atle, BioLamina, Mentimeter, Mercuri International, My Driving Academy, Nodica, Silex, Bure Growth, Atle Fund Management, Alcur Fonder, First Fondene
Press page bure.se/en/press/press-releases

Metrics

Valuation  
Market cap kr 20.011B
Market cap (USD) $ 1.97B
P/E -4.27
PEG —
P/BV 1.01
P/S 66.35
P/OCF 67.61
P/FCF —
Dividend yield 1.0%
Turnover / mcap —
Returns  
ROE -21.0%
ROI -23.6%
ROIC -17.7%
Profit margin —
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 9
Quality score -52.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Revenue 0 0 0 0 0 301.6M 381.6M 415.5M 443.3M 455.1M 485.6M 536.6M 548.9M 772.2M 805.9M 818.9M —
Net profit -4.676B 5.735B 4.749B -9.235B 6.362B 3.236B 4.229B 1.821B 834.1M 1.173B 2.94B 960.7M 179.8M -165.7M -53.5M 571.4M —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Share price 35.4 381.8 285.8 246.4 438.2 — 212 101.8 101 97.25 — — — — — — —
Price performance 12m -0.91 0.34 0.16 -0.44 0.49 — 1.08 0.01 0.04 — — — — — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (SEK) — 0.00 0.00 — — — —
Lease liabilities (SEK) — 3M 4M 3M 3M 3M 3M
Cash and deposits (SEK) 658M 1.17B 326M 416M 1.45B 646M 241M
Right-of-use assets (SEK) — 3M 4M 3M 3M 3M 4M
Cash flow detail
Dividends paid (cash effect) (SEK) — -69M -148M -167M -167M -185M -204M
Share buybacks (cash effect) (SEK) — — 0.00 -1M -1M -1M -1M
Income taxes paid (cash effect) (SEK) — 0.00 0.00 0.00 0.00 0.00 0.00
Share-based compensation (SEK) — — — -1M — — —
Income detail
Total comprehensive income (SEK) — 3.29B 6.36B -9.24B 4.75B 5.74B -4.68B
Comprehensive income to owners (SEK) — 3.29B 6.35B -9.24B 4.75B 5.74B -4.68B
Reported — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Mycronic receives order for an SLX mask writer Bull 1 Bear 0 Other

Mycronic has received an order for an SLX laser mask writer from a new SLX customer in Asia, with an order value of USD 4-6 million and delivery planned for the third quarter of 2027. The customer intends to use the system to address opportunities in the growing advanced packaging market. The SLX meets rising demand for photomasks for the semiconductor industry as well as replacement and modernization needs, and is based on the same technology as Mycronic's display mask writers. This summary was AI-generated.

Source: 

Mycronic AB

Read the original news article here

ADDRESS: NYBROGATAN 6, 114 34 STOCKHOLM, SWEDEN

PHONE: +46 8 614 00 20 EMAIL: [email protected]

Bure was founded in 1992 from the winding up of Sweden’s wage earner investment funds and was listed on Nasdaq Stockholm in 1993. Our goal is to create value and returns for our shareholders by actively developing a diversified portfolio of professionally managed companies and businesses. The cornerstones of our business model are in-depth engagement and a strong presence in the portfolio companies. In this way, we build up extensive expertise in the industries in which our portfolio companies operate. Our current portfolio includes several companies with which we have been involved for a long time and to which we have contributed to successful development.

Copyright © 2020 Bure Equity AB.
All rights reserved.

Yubico will publish its third-quarter report for 2026 on November 5 at 7:00 am CET, followed by a webcast and teleconference at 15:00 CET the same day. CEO Jerrod Chong, CFO Snejana Koleva and Alexandra Barganowski of Investor Relations will present the results and answer questions. Participants can join via the webcast or register for the teleconference to receive dial-in details, with the option to ask questions verbally. This summary was AI-generated.

Source: 

Yubico AB

Read the original news article here

ADDRESS: NYBROGATAN 6, 114 34 STOCKHOLM, SWEDEN

PHONE: +46 8 614 00 20 EMAIL: [email protected]

Bure was founded in 1992 from the winding up of Sweden’s wage earner investment funds and was listed on Nasdaq Stockholm in 1993. Our goal is to create value and returns for our shareholders by actively developing a diversified portfolio of professionally managed companies and businesses. The cornerstones of our business model are in-depth engagement and a strong presence in the portfolio companies. In this way, we build up extensive expertise in the industries in which our portfolio companies operate. Our current portfolio includes several companies with which we have been involved for a long time and to which we have contributed to successful development.

Copyright © 2020 Bure Equity AB.
All rights reserved.

Mycronic has received an order for a Prexision Lite 8 Evo mask writer and a Prexision MMS metrology system from an existing customer in Asia, with an order value of USD 12-14 million. The Prexision Lite 8 Evo, designed for cost-efficient production of display photomasks up to G8 size, is scheduled for delivery in the second quarter of 2027. The Prexision MMS, a replacement system that measures pattern position for photomask quality assurance, is planned for delivery in the third quarter of 2027. This summary was AI-generated.

Source: 

Mycronic AB

Read the original news article here

ADDRESS: NYBROGATAN 6, 114 34 STOCKHOLM, SWEDEN

PHONE: +46 8 614 00 20 EMAIL: [email protected]

Bure was founded in 1992 from the winding up of Sweden’s wage earner investment funds and was listed on Nasdaq Stockholm in 1993. Our goal is to create value and returns for our shareholders by actively developing a diversified portfolio of professionally managed companies and businesses. The cornerstones of our business model are in-depth engagement and a strong presence in the portfolio companies. In this way, we build up extensive expertise in the industries in which our portfolio companies operate. Our current portfolio includes several companies with which we have been involved for a long time and to which we have contributed to successful development.

Copyright © 2020 Bure Equity AB.
All rights reserved.

Privacy settingsPrivacy settings

Prompts

Bure Equity (ticker BURE), listed in Sweden.

ETFs Holding Bure Equity

ETF Weight in ETF Shares Market value As of
AVDS 0.09% 10,799 $ 314.259K Nov 16, 2026
AVDV 0.05% 362,208 $ 10.541M Nov 16, 2026
AVDE 0.01% 80,401 $ 2.34M Nov 16, 2026